BIOCROSSROADS: FrameWORX session: “The Potential Impact of AnalytiXIN”

Event Description

A new era of understanding human health driven by advanced analytics is dawning in Indiana. Our next FrameWORX will highlight how this healthcare approach holds the potential to tackle challenging conditions for both Hoosiers and individuals worldwide.

A virtual 1-hour program will feature the work of AnalytiXIN and several experts including Anthony Philippakis, Chief Data Officer at the Broad Institute, a multidisciplinary community of researchers in Cambridge, Mass. Anthony will talk about what AnalytiXIN can mean for researchers and how it can advance the study of human health. He’ll be joined by Darshan Shah, Executive Vice President of AnalytiXIN, along with Tatiana Foroud, PhD, the Executive Associate Dean for research affairs at the Indiana University School of Medicine, Tim Ryan, a fellow with Lilly Research Laboratories at Eli Lilly and Company, and Tony Pastorino, Vice President of Information Services at Indiana University Health.

AnalytiXIN has become a transformative platform that is driving critical discovery by harnessing the power of artificial intelligence, machine learning, and technologies. A prominent feature under AnalytiXIN is the life sciences health data asset, a clinico-genomic database built and supported by several health care partners across Indiana. The database is a treasure trove of sample collections and clinical data through IU Health and the Indiana Biobank – including racial, ethnic, rural, and urban representations – spanning more than three decades.

We look forward to having you join us!

Free